Analysts predict that Quanterix Corp (NASDAQ:QTRX) will post $6.54 million in sales for the current quarter, according to Zacks. Three analysts have provided estimates for Quanterix’s earnings, with estimates ranging from $6.50 million to $6.61 million. The business is scheduled to issue its next earnings results on Monday, January 1st.
On average, analysts expect that Quanterix will report full year sales of $6.54 million for the current financial year, with estimates ranging from $22.76 million to $22.90 million. For the next fiscal year, analysts forecast that the company will report sales of $34.38 million per share, with estimates ranging from $33.82 million to $35.32 million. Zacks Investment Research’s sales calculations are a mean average based on a survey of research firms that that provide coverage for Quanterix.
A number of research analysts have recently weighed in on QTRX shares. BTIG Research started coverage on Quanterix in a report on Tuesday, January 2nd. They set a “buy” rating and a $26.00 price target on the stock. Leerink Swann started coverage on Quanterix in a report on Tuesday, January 2nd. They set an “outperform” rating and a $27.00 price target on the stock. Cowen started coverage on Quanterix in a report on Tuesday, January 2nd. They set an “outperform” rating on the stock. Finally, JPMorgan Chase & Co. started coverage on Quanterix in a report on Tuesday, January 2nd. They set an “overweight” rating on the stock.
An institutional investor recently bought a new position in Quanterix stock. Jennison Associates LLC acquired a new position in shares of Quanterix Corp (NASDAQ:QTRX) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 295,900 shares of the company’s stock, valued at approximately $6,353,000. Jennison Associates LLC owned about 1.36% of Quanterix as of its most recent filing with the Securities and Exchange Commission. Institutional investors and hedge funds own 1.37% of the company’s stock.
Quanterix (NASDAQ QTRX) opened at $18.56 on Wednesday. Quanterix has a twelve month low of $15.56 and a twelve month high of $24.81.
Quanterix Company Profile
Quanterix Corporation is a United States-based company, which develops tools for high definition diagnostics. The Company offers single molecule array (Simoa) platform, which uses single molecule measurements to access proteins. Simoa focuses on research and clinical testing applications. The Company focuses on research and diagnostics for brain injuries, heart disease, cancer and other diseases with its technology.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Quanterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quanterix and related companies with MarketBeat.com's FREE daily email newsletter.